序号 |
标题 |
次数 |
作者 |
发布时间 |
84061 |
CAS:1402795-92-9 DOTA-(COOt-Bu)3-azide |
157 |
zyl |
2024-11-28 |
84062 |
大环1,4,7,10-四氮杂环十二烷-N,N’,N”,N”-四乙酸(C-DOTA)的钆-树枝状聚合物缀合物 |
99 |
kx |
2024-11-28 |
84063 |
DO-(CH2COOH)2 二乙酸脱氧核酸 |
140 |
zyl |
2024-11-28 |
84064 |
3,3′-偶氮双(6-氨基-1,2,4,5-四嗪)(DAAT) |
128 |
WYQ |
2024-11-28 |
84065 |
3,6-双(1-氢-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
105 |
WYQ |
2024-11-28 |
84066 |
CAS:593287-40-2 大环化合物 |
94 |
zyl |
2024-11-28 |
84067 |
3,6-二叠氮基-1,2,4,5-四嗪(DiAT) |
100 |
WYQ |
2024-11-28 |
84068 |
CAS:1027785-95-0 Ga-DOTA-NOC |
132 |
zyl |
2024-11-28 |
84069 |
DOTAGA-rhCCK-9 |
105 |
wyh |
2024-11-28 |
84070 |
DOTA-Dglu-(Glu)5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2的结构组成 |
127 |
wyh |
2024-11-28 |
84071 |
polylysine-(Gd-DOTA)的介绍 |
143 |
zyl |
2024-11-28 |
84072 |
(R)-DOTAGA-(COOt-Bu)4 817562-90-6 (R)-DOTAGA-四叔丁酯 |
118 |
zcy |
2024-11-28 |
84073 |
Azido-mono-amide-DOTA(B-288) |
147 |
zyl |
2024-11-28 |
84074 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
124 |
wyh |
2024-11-28 |
84075 |
3-羟基-5-取代芳基吡唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
120 |
WYQ |
2024-11-28 |
84076 |
氨基羧酸盐大环NOTA (N(3)O(3)) |
189 |
kx |
2024-11-28 |
84077 |
3,6-二对氯苯基-1,4-二氢-S-四嗪-1,4-二对甲基苯砜基 |
99 |
WYQ |
2024-11-28 |
84078 |
CAS:437608-50-9 Lutathera |
184 |
zyl |
2024-11-28 |
84079 |
3,6-二丙基-N,N'-二甲苯基-1,2,4,5-四嗪-1,4-二甲酰胺 |
114 |
WYQ |
2024-11-28 |
84080 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
91 |
wyh |
2024-11-28 |
84081 |
3,6-二胺基-1,2,4,5-四嗪(DAT) |
129 |
WYQ |
2024-11-28 |
84082 |
CAS:2057438-24-9 Dotatate tfa |
92 |
zyl |
2024-11-28 |
84083 |
3,6-二(对氯苄基)-s-四嗪 |
90 |
WYQ |
2024-11-28 |
84084 |
DOTA-cBR96 , DOTA偶联BR96单克隆抗体 |
120 |
kx |
2024-11-28 |
84085 |
p-NH2-Bn-DOTA-hu14.18K322A |
143 |
wyh |
2024-11-28 |
84086 |
3,6-二(对氯苯基)-s-四嗪 |
101 |
WYQ |
2024-11-28 |
84087 |
DOTA-tri(acid)-amido-PEG3-Bromoacetamide 定制 |
116 |
zcy |
2024-11-28 |
84088 |
CAS:306776-79-4 DOTAGA-tetra (t-Bu ester) |
121 |
zyl |
2024-11-28 |
84089 |
N,N'-二取代基-3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酰胺类化合物 |
115 |
WYQ |
2024-11-28 |
84090 |
DOTA-ZHER2:2891-Affibody |
180 |
wyh |
2024-11-28 |
84091 |
CAS:872469-60-8 大环化合物 |
88 |
zyl |
2024-11-28 |
84092 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)共轭GnRH肽 |
86 |
kx |
2024-11-28 |
84093 |
3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酸甲酯化合物 |
88 |
WYQ |
2024-11-28 |
84094 |
3-氧代-5-取代芳基异唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
88 |
WYQ |
2024-11-28 |
84095 |
cas:619300-53-7 DOTA-NOC;DOTA-Nal3-octreotide |
93 |
zcy |
2024-11-28 |
84096 |
CAS:157599-02-5 1,4,7,10-四(氨基羰甲基)-1,4,7,10-四氮杂环十二烷 |
87 |
zyl |
2024-11-28 |
84097 |
DOTA-peptide-(GGGF)-m170的结构组成 |
155 |
wyh |
2024-11-28 |
84098 |
DOTA-3P-RGD ,双功能螯合剂DOTA偶联环肽RGD二聚体 |
209 |
kx |
2024-11-28 |
84099 |
CAS:913542-71-9 DOTA di(tBu)ester |
91 |
zyl |
2024-11-28 |
84100 |
cas: 1192362-32-5 DOTA-LM3 |
111 |
zcy |
2024-11-28 |
84101 |
DOPE-PEG-DOTA 磷脂-聚乙二醇-大环配体 |
83 |
zyl |
2024-11-28 |
84102 |
DOTA-GX1 , 大环螯合剂DOTA缀合GX1肽 |
95 |
kx |
2024-11-28 |
84103 |
甲氧基DOTA;MeO-DOTA |
248 |
wyh |
2024-11-28 |
84104 |
cas:865470-67-3 DOTA-Thiol |
121 |
zcy |
2024-11-28 |
84105 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-烷基酮 |
94 |
WYQ |
2024-11-28 |